Mapatumumab, an antibody targeting TRAIL-R1, in combination with paclitaxel and carboplatin in patients with advanced solid malignancies: Results of a phase I and pharmacokinetic study
- Stephen Leong
- , Roger B. Cohen
- , Daniel L. Gustafson
- , Corey J. Langer
- , D. Ross Camidge
- , Kristin Padavic
- , Lia Gore
- , Margaret Smith
- , Laura Q. Chow
- , Margaret Von Mehren
- , Cindy O'Bryant
- , Sujatha Hariharan
- , Sami Diab
- , Norma Lynn Fox
- , Renée Miceli
- , S. Gail Eckhardt
Research output: Contribution to journal › Article › peer-review
114
Scopus
citations